Christian Pittard
Known title: DirectorCIK: 0001340575
Christian Pittard's purchase track record
Christian Pittard has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/16/2025 | HQL | $134K | +2.1% | +8.8% | +10.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| HQL | ▲ Buy | Open Market | 7,923 | $134K | 12/16/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
HQL Listed Among Top CEFs for September 2026 Yield
abrdn Life Sciences Investors (HQL) was included in a recent list of the ten best closed-end funds for September 2026, which highlights an average yield of 10%. This inclusion suggests the fund is being noted for its income potential within the broader CEF market. The stock is currently trading near its support level, reflecting a mixed technical picture alongside this fundamental recognition.
HQL Listed Among Top CEFs for September 2026 Yield. abrdn Life Sciences Investors (HQL) was included in a recent list of the ten best closed-end funds for September 2026, which highlights an average yield of 10%. This inclusion suggests the fund is being noted for its income potential within the broader CEF market. The stock is currently trading near its support level, reflecting a mixed technical picture alongside this fundamental recognition.